Newly appointed President of Korea Health Industry Development Institute: Ko Kyung Hwa
Former Congresswoman Ko Kyung Hwa was newly appointed as the president of Korea Health Industry Development Institute
On Friday, July 1st, the minister of Korean Ministry of Health and Welfare appointed former Congresswoman Ko Kyung Hwa to a three year term as the President of Korea Health Industry Development Institute.
President Ko Kyung Hwa was born in 1962, graduated from Ewha Womans University in 1983 with a degree in English Language and Literature, and graduated from Ewha Womans Graduate School in 2000 with a Master's degree in Social Welfare.
From 2002-2004, President Ko served both as a member in the National Policy Planning Committee and as part of an expert panel in the health and welfare division of Korea's Grand National Party-Hannara. She was elected to Congress in 2004 Congressional Election and served in the Korean National Assembly as a member of Health and Welfare Committee and was widely acknowledged as an expert in health and welfare. During her three years of activity in the National Assembly in 2004-2006, she was selected as an outstanding committee member by an administration inspection agency.
During the nomination procedure for President of Korea Health Industry development Institute she was quickly recognized for her highly specialized expertise in the area of health and welfare and was elected as the president.
During her appointment speech, President Ko stated that she will work hard to develop and strengthen Korea's health and medical industry to fit the increasingly competitive global standard and pave a path for the health industry to be a beacon of light among other industries in the future.
Meanwhile, the Korea Health Industry Development Institute is aiming to be a global leader in Healthcare Industry

As the centrally healthcare-based field of biotechnology increases in importance, advanced nations recognize the growing role of the healthcare bio-industry in the world economy. To achieve global competitiveness, nations are undertaking vigorous industry promotion through various efforts, such as R&D support and the development of expert human resources.
With the pharma/bio and global healthcare industries as the new growth engines of the Korean economy, our nation is investing heavily in R&D. Through joint effort, Korea is also working towards a state-of-the-art medical system, developing new technology, finding ways to spread into the global market, and attracting foreign patients, among other tasks. Amidst this globally competitive environment, KHIDI has persistently supported the efforts of the Korean healthcare industry.
KHIDI USA was established to promote awareness of the needs of and importance of the healthcare industry. Committed to helping the Korean healthcare industry achieve global competence and competitiveness, KHIDI seeks your understanding, cooperation, and active support in our endeavors.